We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+13.36%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.74B
AUM Growth
+$243M
Cap. Flow
-$49.7M
Cap. Flow %
-1.81%
Top 10 Hldgs %
26.17%
Holding
142
New
11
Increased
53
Reduced
58
Closed
13

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$23.8M
2
INMD icon
InMode
INMD
+$23.7M
3
VRT icon
Vertiv
VRT
+$22.9M
4
CMCSA icon
Comcast
CMCSA
+$22.4M
5
PYPL icon
PayPal
PYPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 26.76%
2 Healthcare 12.9%
3 Consumer Discretionary 11.35%
4 Financials 11.17%
5 Communication Services 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEYS icon
26
Keysight
KEYS
$58.3B
$29.1M 1.06%
140,966
-25
-0% -$4.68K
MA icon
27
Mastercard
MA
$493B
$28.9M 1.05%
80,398
-5,127
-6% -$1.77M
EL icon
28
Estee Lauder
EL
$32B
$28.7M 1.05%
77,523
-1,044
-1% -$354K
MU icon
29
Micron Technology
MU
$991B
$28.3M 1.03%
303,483
-7,725
-2% -$603K
ETN icon
30
Eaton
ETN
$174B
$27.5M 1%
159,304
-5,571
-3% -$923K
PG icon
31
Procter & Gamble
PG
$339B
$27.5M 1%
167,948
-806
-0.5% -$120K
META icon
32
Meta Platforms (Facebook)
META
$1.51T
$27.4M 1%
81,474
-1,455
-2% -$483K
NEE icon
33
NextEra Energy
NEE
$177B
$27.3M 1%
292,350
+8,853
+3% +$765K
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$27M 0.99%
250,742
+210
+0.1% +$22.9K
IQV icon
35
IQVIA
IQV
$39.3B
$26.9M 0.98%
95,225
+1,113
+1% +$289K
DHR icon
36
Danaher
DHR
$144B
$26.5M 0.97%
90,710
-5,422
-6% -$1.49M
DE icon
37
Deere & Co
DE
$168B
$26.3M 0.96%
76,784
-1,440
-2% -$501K
KLIC icon
38
Kulicke & Soffa
KLIC
$4.78B
$26.3M 0.96%
434,199
-31,885
-7% -$1.82M
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.13T
$25.9M 0.95%
86,625
+2,473
+3% +$708K
CVS icon
40
CVS Health
CVS
$122B
$25.8M 0.94%
250,559
+4,060
+2% +$375K
TMO icon
41
Thermo Fisher Scientific
TMO
$220B
$24.7M 0.9%
37,031
-2,259
-6% -$1.41M
COST icon
42
Costco
COST
$420B
$24.4M 0.89%
42,929
-2,227
-5% -$1.14M
BLK icon
43
Blackrock
BLK
$176B
$24.3M 0.89%
26,533
+612
+2% +$558K
TNL icon
44
Travel + Leisure Co
TNL
$4.7B
$24.2M 0.88%
437,126
+34,115
+8% +$1.82M
ANET icon
45
Arista Networks
ANET
$238B
$24M 0.88%
+669,120
New +$20M
CTAS icon
46
Cintas
CTAS
$81.3B
$24M 0.88%
216,972
-2,196
-1% -$237K
CZR icon
47
Caesars Entertainment
CZR
$6.14B
$23.5M 0.86%
250,756
+6,857
+3% +$695K
CBRE icon
48
CBRE Group
CBRE
$42.9B
$22.7M 0.83%
209,459
+103,849
+98% +$10.6M
JNJ icon
49
Johnson & Johnson
JNJ
$625B
$22.7M 0.83%
132,854
-8,103
-6% -$1.33M
DHI icon
50
D.R. Horton
DHI
$42.3B
$22.5M 0.82%
207,290
-965
-0.5% -$92.9K

Similar funds

Braun Stacey Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Braun Stacey Associates held 142 positions worth $2.74B, up 9.7% from $2.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Braun Stacey Associates's Q4 2021 filing shows 11 new, 53 increased, 58 reduced and 13 closed positions. Its largest new stake was Marvell Technology: 334,218 shares worth $29.2M. The largest sale was Adobe, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Braun Stacey Associates's largest Q4 2021 buy was Marvell Technology: 334,218 shares worth $29.2M.
  • Braun Stacey Associates added most to CBRE Group in Q4 2021, an estimated $10.6M increase.
  • Braun Stacey Associates's biggest Q4 2021 reduction was InMode, cutting an estimated $23.7M.
  • Braun Stacey Associates fully exited Adobe in Q4 2021, selling an estimated $23.8M.
  • Braun Stacey Associates's ten largest holdings make up 26% of its $2.74B portfolio in Q4 2021.
  • Braun Stacey Associates opened 11 new positions and closed 13 in Q4 2021.
  • Braun Stacey Associates's portfolio value rose 9.7% quarter-over-quarter to $2.74B.

Based on Braun Stacey Associates's 13F filing for Q4 2021, filed 25 Jan 2022.